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OBJECTIVE — Previous studies, largely in northern Europe, have suggested an association
between type 1 diabetes and reduced serum 25-hydroxy(OH) vitamin D levels, a concept we
tested in individuals residing in a solar-rich region (Florida).
RESEARCH DESIGN AND METHODS — Serum samples from 415 individuals resid-
inginFloridawerecross-sectionallyanalyzed:153controlsubjects,46new-onsettype1diabetic
patients, 110 established type 1 diabetic patients (samples 5 months from diagnosis), and 106
ﬁrst-degree relatives of the diabetic patients.
RESULTS — Inthisstudy,25-OHvitaminDlevels(median,range,interquartilerange[IQR])
were similar among control subjects (20.1, below detection [bd]–163.5, 13.0–37.4 ng/ml),
new-onsettype1diabeticpatients(21.2,bd–48.6,12.2–30.2ng/ml),establishedtype1diabetic
patients (23.2, bd–263.8, 13.8–33.9 ng/ml), and ﬁrst-degree relatives (22.2, bd–59.9, 12.7–
33.1 ng/ml) (P  0.87). Mean 25-OH vitamin D levels were less than the optimal World Health
Organization level of 30 ng/ml in all study groups.
CONCLUSIONS — Reducedserum25-OHvitaminDlevelswerenotspeciﬁcallyassociated
with type 1 diabetes. The uniform suboptimal 225-OH vitamin D levels, despite residence in a
zone with abundant sunshine, support additional dietary vitamin D fortiﬁcation practices.
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T
heroleforenvironmentinthedevel-
opment of type 1 diabetes has re-
mained elusive, with multiple
factorspurportedtomodulateriskforthis
disease (e.g., viruses, breast-feeding, age
for cereal introduction, and childhood
immunizations) (1,2). Further to this list
is vitamin D levels (3), with previous
studiessuggestingtype1diabeticpatients
had lower serum concentrations of this
metabolite than healthy control subjects
(4–6) as well as disease-associated poly-
morphisms in a vitamin D metabolism
gene (7). Although certainly intriguing,
we note the aforementioned studies were
largely undertaken in northern European
countries (4,5), whereas the one study
performed in the U.S. failed to provide
values among healthy control subjects
and, hence, did not identify disease spec-
iﬁcity (6). Therefore, we measured serum
25-hydroxy (OH) vitamin D levels from
type 1 diabetic patients, their ﬁrst-degree
relatives, and healthy control subjects all
residing in a solar-rich region (Florida).
RESEARCH DESIGN AND
METHODS— Serum from 415 indi-
viduals was obtained from healthy
control subjects (type 1 diabetes auto-
antibody negative, no family history of
type 1 diabetes, median age 22.0 years,
age range 5.0–65.1 years, 84 female, and
153 total), new-onset type 1 diabetic pa-
tients with diabetes 5 months duration
(12.2 years, 5.9–35.0 years, 23 female,
and 46 total), established type 1 diabetic
patients with diabetes 5 months dura-
tion (16.0 years, 5.1–62.6 years, 50 fe-
male, and 110 total), and relatives of
those with type 1 diabetes (21.0 years,
1.0–62.6 years, 54 female, and 106 to-
tal). All samples were collected with in-
formedconsentwithUniversityofFlorida
Institutional Review Board approval. As a
retrospective study of de-identiﬁed sam-
ples,noinformationregardingsunavoid-
ance routines or dietary practices
(including vitamin D fortiﬁcation) were
available, nor were methods for case
matching permissible.
25-OH vitamin D levels were quanti-
ﬁed in duplicate with a commercial en-
zyme immunosorbent assay kit (ALPCO,
Salem, NH), an analyte shown previously
as stable in storage (8). This assay mea-
sures both D2 and D3 forms of 25-OH
vitamin D. The intra- and interassay coef-
ﬁcients of variation for this assay were
10.7 and 13.2%, respectively. The lower
limit of detection was 2.56 ng/ml. 25-OH
vitamin D deﬁciency was deﬁned as 20
ng/ml, insufﬁciency as 21–30 ng/ml, and
sufﬁciency as 30 ng/ml (9,10).
Analysis of multiple unpaired group
comparisons were achieved using the
nonparametricKruskal-WalliswithDunn
posttest to correct for multiple compari-
sons (11). Age and 25-OH vitamin D re-
lationships were analyzed by linear
regression, with two-tailed Fisher exact
test used to compare proportions of sub-
jects deemed insufﬁcient. Power calcula-
tions were performed post hoc with
GraphPad StatMate version 2.00 (Graph-
Pad Software, San Diego, CA; www.
graphpad.com), revealing an 80% power
to detect a 10.5 ng/ml difference in
25-OH vitamin D levels.
RESULTS— 25-OH vitamin D levels
(median, range, interquartile range
[IQR]) were as follows: healthy control
subjects (20.1, below detection [bd]–
163.5,13.0–37.4ng/ml),new-onsettype
1 diabetic patients (21.2, bd–48.6, 12.2–
30.2 ng/ml), established type 1 diabetic
patients (23.2, bd–263.8, 13.8–33.9 ng/
ml), and ﬁrst-degree relatives (22.2, bd–
59.9, 12.7–33.1 ng/ml) (Fig. 1A). The
medians were not different among indi-
viduals in these cohorts (P  0.87). Sub-
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ml) were observed in 70.1% of control
subjects, 76.1% of new-onset type 1 dia-
beticpatients,68.5%ofestablishedtype1
diabetic patients, and 68.8% of ﬁrst-
degree relatives; values, although low,
were not signiﬁcantly different from each
other (P  0.46).
Comparison of age with serum
25-OH vitamin D levels indicated that for
all groups combined, r
2  0.004 and P 
0.22. Comparison of age with serum
25-OH vitamin D levels for individual
groups were for healthy control subjects,
r
2  0.010 and P  0.21; new-onset type
1 diabetic patients, r
2  0.0001 and P 
0.96; established type 1 diabetic patients,
r
20.013andP0.24;andﬁrst-degree
relatives, r
2  0.075 and P  0.005.
Hence, regression analysis revealed no
trend in 25-OH vitamin D levels as it per-
tained to overall age.
Because sunlight plays a major role in
vitamin D synthesis, we then examined
25-OH vitamin D levels as a function of
themonththesamplewasdrawnasasur-
rogate marker of ultraviolet (UV) B expo-
sure (Fig. 1C). Comparison of the 25-OH
vitamin D levels among each 3-month
block showed no signiﬁcant difference
(P  0.78). Further analysis revealed no
signiﬁcantdifferencesonamonthlyexpo-
sure basis when examining control sub-
jects versus new-onset type 1 diabetic
patients, established type 1 diabetic pa-
tients, or ﬁrst-degree relatives (P  0.71).
CONCLUSIONS — Our study did
not ﬁnd signiﬁcant differences in 25-OH
vitamin D levels among healthy control
subjects, type 1 diabetic patients, and
ﬁrst-degree relatives of diabetic patients
Figure 1—25-OH vitamin D levels in cohorts based on parameters of disease, age, or estimated solar exposure. For disease status (A), values are
presentedasafunctionofstudygroupwithdeﬁnitionsofinsufﬁciency(orangeline)anddeﬁciency(redline)provided.Withrespecttoage(B),values
forallstudyparticipantsindependentofcohortareshownwiththedeﬁnitionsofinsufﬁciencyanddeﬁciencyasdeﬁnedinAalongwithagecorrelation
(blueline).C:EstimatedaverageUVBexposurefortheentirestudypopulationispresented.UVIclimatologicaldatawereobtainedfromtheNational
Weather Service (NWS) and U.S. Environmental Protection Agency (EPA) Web sites (http://www.cpc.ncep.noaa.gov and http://www.epa.gov) to
determine relative UV exposure. Based on data for the previous 5 years, for the proximate city of Jacksonville, Florida, we established the mean UV
exposure for each month: January, 3.215; February, 4.08; March, 5.96; April, 7.68; May, 8.238; June, 8.578; July, 8.976; August, 8.254; September,
6.902;October,5.11;November,3.694;andDecember,2.79.ThenumberscorrespondtotheUVIscale(1–11)developedbytheNWSandEPAand
implemented by the World Health Organization. The samples were grouped according to month drawn and placed into one of four possible 3-month
blocks, each block formed on the basis of similar UVB indexes. The 25-OH vitamin D levels (reported as median, range, IQR) for the November/
December/Januarygroupof112samples(20.7,bd–263.8,12.7–33.6ng/ml)withanaverageestimatedUVexposureof3.23.TheOctober/February/
March group of 113 samples (20.8, bd–146.8, 12.7–31.5 ng/ml) with an average estimated UV exposure of 5.05. The September/April/May group
of84samples(19.3,bd–163.5,14.0–36.9ng/ml)withanaverageestimatedUVexposureof7.61.TheJune/July/Augustgroupof106samples(23.9,
bd–82.9, 13.4–35.6 ng/ml) with an average estimated UV exposure of 8.60.
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of the U.S. However, more surprisingly,
we identiﬁed that within each group,
there exists a high frequency of vitamin D
insufﬁciency, even in the sun-rich envi-
ronment of Florida.
For analysis of UV exposure, we
elected to group samples by similarity in
UV index (UVI) (to increase statistical
power). In addition, we performed anal-
ysis in a month-by-month fashion. By ei-
ther method, no differences among the
study groups were observed. Although
wemayhaveintroducedanecologicalfal-
lacy bias in assigning UVI aggregate data
to individual subjects, other factors such
as sun avoidance practices to inadequate
supplementationmayalsoaccountforthe
low 25-OH vitamin D levels observed in
this cross-sectional study. These biases
may also be present in studies examining
geographical distribution (12). Another
possibility is that at Florida’s latitude, the
duration of sunlight hours per day does
not vary as dramatically as that which oc-
curs closer to the geographical poles,
thereby providing a mechanism to ex-
plain our lack in seasonal variation for
25-OH vitamin D levels.
With respect to race/ethnicity, a vari-
able that has previously been noted to in-
ﬂuence 25-OH vitamin D levels (13), our
study was reﬂective of the prevalence of
type1diabetesamongallraces,andgiven
the predominance for this disease in Cau-
casians, it was not of sufﬁcient power to
analyze such a variable. However, the fre-
quency of samples from non-Caucasians
did not differ signiﬁcantly among the
study groups (data not shown). Indeed,
the issue of sample size is one worth not-
ing. As mentioned previously, the study
herein was of a size larger than those re-
portinganegativeassociationbetweense-
rum 25-OH vitamin D levels and type 1
diabetes, with our current study (based
onitssize)havinga20%chanceofreport-
ing a statistical type 2 error (false nega-
tive). Hence, future efforts that are larger,
prospective, and take into account analy-
sis of additional factors (e.g., skin type,
vitamin D fortiﬁcation practices, photo-
protection behaviors, time spent out-
doors, etc.) that may inﬂuence serum
25-OH vitamin D would be beneﬁcial.
This, as well as the question addressing
25-OHvitaminDlevelsinanorthernU.S.
state, should be addressed in the future.
Given the amount of UV available to
those residing in Florida and the fortiﬁca-
tion of milk products with vitamin D, the
lowserumlevelsof25-OHvitaminDthat
were found add credence to the recent
recommendation by the American Acad-
emyofPediatricstodoubletheamountof
vitamin D supplementation provided to
children (14). Given that our results con-
trastwiththoseofseveralotherefforts(4–
6), additional studies using a prospective
cohort design to further deﬁne the role of
vitamin D in the pathogenesis of type 1
diabetes are urgently needed because tri-
als using active forms of this metabolite
for type 1 diabetes prevention are actively
being considered.
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